News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,403 Results
Type
Article (40492)
Company Profile (272)
Press Release (666638)
Multimedia
Podcasts (59)
Webinars (13)
Section
Business (205271)
Career Advice (2026)
Deals (35566)
Drug Delivery (97)
Drug Development (81336)
Employer Resources (172)
FDA (16283)
Job Trends (14946)
News (346851)
Policy (32711)
Tag
Academia (2577)
Accelerated approval (7)
Adcomms (22)
Allergies (93)
Alliances (49936)
ALS (104)
Alzheimer's disease (1427)
Antibody-drug conjugate (ADC) (153)
Approvals (16280)
Artificial intelligence (301)
Autoimmune disease (27)
Automation (18)
Bankruptcy (364)
Best Places to Work (11667)
BIOSECURE Act (20)
Biosimilars (114)
Biotechnology (190)
Bladder cancer (89)
Brain cancer (31)
Breast cancer (356)
Cancer (2765)
Cardiovascular disease (204)
Career advice (1694)
Career pathing (30)
CAR-T (180)
CDC (28)
Cell therapy (487)
Cervical cancer (22)
Clinical research (66815)
Collaboration (983)
Company closure (3)
Compensation (639)
Complete response letters (19)
COVID-19 (2631)
CRISPR (54)
C-suite (300)
Cystic fibrosis (109)
Data (2848)
Decentralized trials (2)
Denatured (22)
Depression (55)
Diabetes (339)
Diagnostics (6442)
Digital health (23)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (133)
Drug pricing (120)
Drug shortages (27)
Duchenne muscular dystrophy (118)
Earnings (87534)
Editorial (40)
Employer branding (21)
Employer resources (147)
Events (114198)
Executive appointments (843)
FDA (17854)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (907)
Gene editing (126)
Generative AI (21)
Gene therapy (361)
GLP-1 (769)
Government (4494)
Grass and pollen (4)
Guidances (180)
Healthcare (18872)
Huntington's disease (30)
IgA nephropathy (36)
Immunology and inflammation (140)
Immuno-oncology (7)
Indications (38)
Infectious disease (2790)
Inflammatory bowel disease (151)
Inflation Reduction Act (12)
Influenza (59)
Intellectual property (114)
Interviews (313)
IPO (16613)
IRA (46)
Job creations (3671)
Job search strategy (1435)
Kidney cancer (13)
Labor market (50)
Layoffs (493)
Leadership (18)
Legal (7960)
Liver cancer (78)
Lung cancer (389)
Lymphoma (199)
Machine learning (9)
Management (58)
Manufacturing (363)
MASH (84)
Medical device (13469)
Medtech (13474)
Mergers & acquisitions (19633)
Metabolic disorders (821)
Multiple sclerosis (96)
NASH (16)
Neurodegenerative disease (111)
Neuropsychiatric disorders (31)
Neuroscience (2079)
NextGen: Class of 2025 (6557)
Non-profit (4500)
Now hiring (47)
Obesity (414)
Opinion (221)
Ovarian cancer (95)
Pain (101)
Pancreatic cancer (115)
Parkinson's disease (183)
Partnered (22)
Patents (285)
Patient recruitment (143)
Peanut (49)
People (57964)
Pharmaceutical (67)
Pharmacy benefit managers (20)
Phase I (20848)
Phase II (29439)
Phase III (21894)
Pipeline (1561)
Policy (192)
Postmarket research (2564)
Preclinical (8882)
Press Release (64)
Prostate cancer (133)
Psychedelics (32)
Radiopharmaceuticals (252)
Rare diseases (441)
Real estate (5962)
Recruiting (65)
Regulatory (22599)
Reports (50)
Research institute (2333)
Resumes & cover letters (352)
Rett syndrome (9)
RNA editing (8)
RSV (45)
Schizophrenia (80)
Series A (154)
Series B (102)
Service/supplier (13)
Sickle cell disease (57)
Special edition (18)
Spinal muscular atrophy (147)
Sponsored (31)
Startups (3640)
State (2)
Stomach cancer (13)
Supply chain (73)
Tariffs (55)
The Weekly (35)
Vaccines (753)
Venture capital (52)
Weight loss (253)
Women's health (43)
Worklife (16)
Date
Today (139)
Last 7 days (523)
Last 30 days (2451)
Last 365 days (31543)
2025 (15742)
2024 (35343)
2023 (40196)
2022 (51308)
2021 (55860)
2020 (54178)
2019 (46667)
2018 (35161)
2017 (32250)
2016 (31662)
2015 (37738)
2014 (31490)
2013 (26547)
2012 (28827)
2011 (29476)
2010 (27562)
Location
Africa (723)
Alabama (61)
Alaska (7)
Arizona (243)
Arkansas (13)
Asia (38393)
Australia (6290)
California (7252)
Canada (2268)
China (644)
Colorado (308)
Connecticut (312)
Delaware (186)
Europe (82621)
Florida (1082)
Georgia (243)
Hawaii (1)
Idaho (59)
Illinois (629)
India (27)
Indiana (358)
Iowa (16)
Japan (215)
Kansas (109)
Kentucky (28)
Louisiana (13)
Maine (64)
Maryland (1001)
Massachusetts (5380)
Michigan (244)
Minnesota (440)
Mississippi (3)
Missouri (86)
Montana (28)
Nebraska (25)
Nevada (78)
New Hampshire (67)
New Jersey (2010)
New Mexico (28)
New York (2037)
North Carolina (1057)
North Dakota (8)
Northern California (3189)
Ohio (231)
Oklahoma (15)
Oregon (35)
Pennsylvania (1575)
Puerto Rico (17)
Rhode Island (37)
South America (1103)
South Carolina (33)
South Dakota (1)
Southern California (2699)
Tennessee (123)
Texas (1085)
United States (26892)
Utah (214)
Virginia (179)
Washington D.C. (73)
Washington State (617)
West Virginia (4)
Wisconsin (65)
707,403 Results for "pulse biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference
May 7, 2025
·
1 min read
Press Releases
Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer
February 4, 2025
·
4 min read
Press Releases
Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results
May 8, 2025
·
11 min read
Press Releases
Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
December 24, 2024
·
5 min read
Press Releases
Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer
January 10, 2025
·
4 min read
Press Releases
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 23, 2025
May 26, 2025
·
2 min read
Press Releases
Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants
December 19, 2024
·
1 min read
Press Releases
Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting
May 1, 2025
·
4 min read
Press Releases
Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting
April 23, 2025
·
4 min read
Deals
Pulse Biosciences, Inc. Announces Commencement of Rights Offering - June 4, 2024
Pulse Biosciences, Inc. today announced that it has commenced its previously announced rights offering of up to $60,000,000 of units (the “Units,” and each, a “Unit”) at the Initial Price (as defined below).
June 4, 2024
·
7 min read
1 of 70,741
Next
